Clinical Trial Update: Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing 99mTc-EC-DG SPECT/CT with 18F FDG PET/CT in patients with Non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• 18F-FDG (fluorodeoxyglucose F-18)
• 99mTc-EC-DG (Technetium-99m EC-DG)

Snippet

Sponsor: Cell>Point LLC | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED